SUBSCRIBE
SUBSCRIBE

GlaxoSmithKline

NEWS
India Companies Hire Honchos of Rival Brands Such as Sanofi (France), GlaxoSmithKline
September 19, 2011
 · 
1 min read
Research into Brain Disorders Under Threat as Drug Firms Like GlaxoSmithKline and AstraZeneca PLC Pull Out
June 14, 2011
 · 
1 min read
Pharm Country
Swine Flu Variation Emerges With Power to Resist Drugs from Roche Holding AG and GlaxoSmithKline
June 10, 2011
 · 
1 min read
GlaxoSmithKline CEO: Emerging-Markets Business Offsets Generics
May 26, 2011
 · 
1 min read
BioCapital
GlaxoSmithKline’s Avandia - When a Drug is on The Market, But Not Really; Drug Officially Gone From US Pharmacies in November
May 19, 2011
 · 
1 min read
BioCapital
Dana-Farber Cancer Institute Study on GlaxoSmithKline’s Avandia Raises Hope For Safer Diabetes Drugs
July 22, 2010
 · 
1 min read
Policy
GlaxoSmithKline Withheld Avandia Study, Ex-Regulator Said to Testify
July 12, 2010
 · 
1 min read
Recall Or Reassurance On Safety Of GlaxoSmithKline’s Avandia? The Countdown Begins...
July 6, 2010
 · 
1 min read
Policy
GlaxoSmithKline Chief Andrew Witty Calls For Drugs Overhaul
June 22, 2010
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Deals
GlaxoSmithKline Adds 3 Weeks for Human Genome Sciences, Inc. Tender
June 8, 2012
 · 
1 min read
FDA
GlaxoSmithKline and XenoPort, Inc. Receive FDA Approval for Horizant® for Postherpetic Neuralgia
June 7, 2012
 · 
7 min read
BioCapital
Human Genome Sciences, Inc. Response to GlaxoSmithKline Press Release
June 4, 2012
 · 
1 min read
Drug Development
GlaxoSmithKline Melanoma Drugs Beat Chemo in Pivotal Trials
June 4, 2012
 · 
1 min read
BioCapital
Human Genome Sciences, Inc. Response to GlaxoSmithKline Press Release
June 1, 2012
 · 
1 min read
Policy
GlaxoSmithKline Partner Pronova BioPharma Wins Lovaza Patent Case Against Teva Pharmaceutical Industries Limited & Par Pharmaceutical, Inc.
May 31, 2012
 · 
1 min read
Business
GlaxoSmithKline’s Stiefel Laboratories Pays Welichem Biotech Inc. $50 Million for Topical Agent for Psoriasis, Atopic Dermatitis
May 31, 2012
 · 
2 min read
Deals
GlaxoSmithKline Eyes Replacing Human Genome Sciences, Inc. Board
May 31, 2012
 · 
1 min read
Biotech Beach
Ligand Pharmaceuticals Inc. Partner GlaxoSmithKline Submits US and European Regulatory Applications for use of PROMACTA/REVOLADE to Increase Platelet Counts in Patients with Hepatitis C
May 30, 2012
 · 
1 min read
Business
CDRD and CDRD Ventures Inc. Enter into a Collaboration With GlaxoSmithKline to Advance the Development and Commercialization of Canadian Health Research
May 30, 2012
 · 
4 min read
Load More